| 000 | 01407 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515170335.0 | ||
| 264 | 0 | _c20090713 | |
| 008 | 200907s 0 0 eng d | ||
| 022 | _a1744-8336 | ||
| 024 | 7 |
_a10.1586/eri.09.19 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThomas, Lyn | |
| 245 | 0 | 0 |
_aDiagnosis and treatment of aspergillosis in children. _h[electronic resource] |
| 260 |
_bExpert review of anti-infective therapy _cMay 2009 |
||
| 300 |
_a461-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAmphotericin B _xtherapeutic use |
| 650 | 0 | 4 |
_aAntifungal Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAspergillosis _xdiagnosis |
| 650 | 0 | 4 | _aCaspofungin |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aEchinocandins _xtherapeutic use |
| 650 | 0 | 4 |
_aFungal Vaccines _xisolation & purification |
| 650 | 0 | 4 | _aGenomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunocompromised Host |
| 650 | 0 | 4 |
_aLipopeptides _xtherapeutic use |
| 650 | 0 | 4 | _aMicafungin |
| 650 | 0 | 4 |
_aPyrimidines _xtherapeutic use |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTriazoles _xtherapeutic use |
| 650 | 0 | 4 | _aVoriconazole |
| 700 | 1 | _aBaggen, Lonneke | |
| 700 | 1 | _aChisholm, Julia | |
| 700 | 1 | _aSharland, Mike | |
| 773 | 0 |
_tExpert review of anti-infective therapy _gvol. 7 _gno. 4 _gp. 461-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1586/eri.09.19 _zAvailable from publisher's website |
| 999 |
_c18830884 _d18830884 |
||